Linked e-resources

Details

Series Editors' Introduction; Acknowledgements; Contents; Notes on Contributors; List of Abbreviations; List of Figures ; List of Tables ; 1: Emerging Technologies for Diagnosing Alzheimer's Disease: Innovating withßCare; The Desirability ofßBiomarker Diagnostics ofßAlzheimer's Disease; Responsible Innovation; Innovating withßCare; Chapter Outline; References; Part I: Biomedical Research onßAlzheimer's Disease Diagnostics: Background andßTrends; 2: The Diagnosis andßTreatment ofßAlzheimer's: Are WeßBeing (Ir)responsible?; History ofßDiagnosis and Treatment.

Current State ofßtheßAlzheimer's Field Crafting anßInnovative But Responsible Future; Early or Timely Diagnosis; Finding theßCure or Even anßEffective Therapy; A Case Study ofß'Irresponsibility'; Towards aßMore Responsible Future; New Approaches; References; 3: On Short Cuts: TheßComplexity ofßStudying theßEarly Diagnosis andßPrevention ofßAlzheimer's Disease; Two Decades, One Question; Around 1993; Around 2013; Even Milder Than Mild Cognitive Impairment: Prevention andßPrediction; Simplifications andßShort Cuts: OnßStudying Early Dementia; References.

4: Biomarkers forßAlzheimer's Disease: Searching forßtheßMissing Link Between Biology andßClinic Biomarkers: Connecting Biology andßClinic; AD Biomarker Research: Development andßClinical Drivers; AD Biomarker Research inßPractice: TheßLeARN Project; Choosing Candidate Markers andßTechnological Platforms; Choosing Outcome Measures; Choices Related toßPatient Inclusion andßFollow-Up; Conclusion; References; 5: Care andßResponsibility inßBuilding Futures forßAlzheimer's Disease Research; Cohort Studies; The Sociality ofßCohorts; The MRC Cognitive Function andßAgeing Study.

Mediating theßCognitive Function andßAgeing Study Meeting theßCohort; Care andßResponsibility; References; Part II: Diagnosing Alzheimer's Disease: Current Practices; 6: Grey Matters: Emergent Biomarkers andßGood Alzheimer's Diagnostics; Background andßMethods; Current Practices ofßAD-Diagnostics inßtheßNetherlands: AßHeterogeneous Field; Good AD-Diagnostics: Differences; The Good Diagnosis: Five Diagnostic Values; Modes ofßDiagnosing: 'Pulling Out All theßStops' or 'Holding Back'; Distributing Differences; Distribution by Taxonomic Considerations.

Distribution by Patients' Preferences Revisiting Current Practices ofßAD-Diagnostics: FromßGood toßBetter?; Value-Laden Taxonomies andßTaxonomy-Laden Preferences; Improving Practices ofßAD-Diagnostics; To Conclude: Emergent Biomarker Tools forßAD; References; 7: Understanding Cognitive Screening Tools: Navigating Uncertainty inßEveryday Clinical Practice; Methods; Clinician-Patient Interaction: Making ofßProvisionality; National Dementia CQUIN andßEarly Diagnosis: Constraining 'Care Work'; Discussion; References.

Browse Subjects

Show more subjects...

Statistics

from
to
Export